TechnologyFriday 02.11.22

Biotech company Novavax reports that its COVID-19 vaccine for adolescents ages 12-17 is 82% effective.

Want to show your appreciation for The Recount's coverage?
Tip us!Tip us!

Recount Wire

ADVERTISEMENT